All USA USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA); USA Compact Free Associations:The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA) International, Israel and Canada.
Grants of up to $75,000 per year to USA, Canada, and International researchers affiliated with qualified institutions for research projects related to juvenile myositis. Funding is intended to advance research to improve medical treatment and work towards a cure for the disease. Eligible uses of funding include equipment, travel, salary support, supplies, and other research-related items.
Grant applications are called for across programs relating to all aspects of; basic research, clinical trials, translational studies, diagnosis, and clinical care of juvenile myositis. A pertinent but not exhaustive list of priorities includes:
Conducting analyses on samples and/or data available from innovative treatment clinical studies.
Collaboration with pharmaceutical companies or other research organizations that are developing new therapies that may have utility in the treatment of juvenile myositis. The collaboration may comprise the generation of clinical protocols for new treatments and a defined route to funding a clinical study. Such proposals should include solid evidence of access to the therapy being proposed for investigation.
Clinical protocols for repurposed drugs for the treatment of juvenile myositis. Such proposals should include solid evidence of access to the therapy being proposed for investigation and a defined route to funding a clinical study.
Investigations of in vitro or in vivo models of juvenile myositis with the objective of the development of new therapies.
Novel diagnostic strategies, including the development of biomarkers.
All aspects of clinical care, spanning mental health and consensus treatment protocols
Applicants must hold a Ph. D. or M.D. degree or equivalent and work in an accredited medical school, university, hospital, or research institute, which must agree to supply the clinical and/or laboratory facilities. The foundation strongly encourages collaborations from two or more institutions that bring together a spectrum of expertise.
- Request for Proposals Begins: May 30, 2023
- Application Deadline: July 30th, 2023
- Review of Submitted Applications Completed: September, 2023
- Anticipated Date for Notification of Awards: October, 2023
- Anticipated Funding Start Date: November 1, 2023